Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
POU class 4 homeobox 3 (POU4F3) is a protein-coding gene encoding a transcription factor that belongs to the POU-domain family. It contains two highly conserved DNA-binding domains—a POU-specific domain and a POU homeodomain—allowing it to regulate genes essential for the maturation, differentiation, and survival of sensory hair cells in the cochlea and vestibular system of the inner ear. POU4F3 acts as a pioneer transcription factor, opening condensed chromatin to enable hair cell development, and controls key downstream targets that inhibit apoptosis and support cell maintenance. Variants disrupting its DNA binding or nuclear localization lead to progressive deafness and are major Mendelian causes of non-syndromic sensorineural hearing loss (DFNA15). In animal models, complete loss results in severe hearing and balance disorders due to hair cell degeneration and secondary neuron loss in auditory pathways.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on POU class 4 homeobox 3 (POU4F3).